Structural disorder throws new light on moonlighting

Trends in Biochemical Sciences

Volumn 30, Issue 9, 2005, Pages 484-489

  Tompa, Peter ^a   Szász, Csilla ^a   Buday, László ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CALPASTATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GLOBULAR PROTEIN; INTRINSICALLY UNSTRUCTURED PROTEIN; PROTEIN MDM2; SECURININE; THYMOSIN BETA4; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

EVOLUTION; HUMAN; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

EID: 23944514504     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2005.07.008     Document Type: Article

References (49)

1. Consortium Finishing the euchromatic sequence of the human genome Nature 431 2004 931 945
2. D.A. Petrov Evolution of genome size: new approaches to an old problem Trends Genet. 17 2001 23 28
3. J.S. Mattick Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms Bioessays 25 2003 930 939
4. C.J. Jeffery Moonlighting proteins Trends Biochem. Sci. 24 1999 8 11
5. C.J. Jeffery Multifunctional proteins: examples of gene sharing Ann. Med. 35 2003 28 35
6. C.J. Jeffery Molecular mechanisms for multitasking: recent crystal structures of moonlighting proteins Curr. Opin. Struct. Biol. 14 2004 663 668
7. P.E. Wright, and H.J. Dyson Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm J. Mol. Biol. 293 1999 321 331
8. P. Tompa Intrinsically unstructured proteins Trends Biochem. Sci. 27 2002 527 533
9. A.K. Dunker Intrinsic disorder and protein function Biochemistry 41 2002 6573 6582
10. A.L. Fink Natively unfolded proteins Curr. Opin. Struct. Biol. 15 2005 35 41
11. H.J. Dyson, and P.E. Wright Intrinsically unstructured proteins and their functions Nat. Rev. Mol. Cell Biol. 6 2005 197 208
12. L. Iakoucheva Intrinsic disorder in cell-signaling and cancer-associated proteins J. Mol. Biol. 323 2002 573 584
13. J.J. Ward Prediction and functional analysis of native disorder in proteins from the three kingdoms of life J. Mol. Biol. 337 2004 635 645
14. P. Tompa, and P. Csermely The role of structural disorder in the function of RNA and protein chaperones FASEB J. 18 2004 1169 1175
15. R.W. Kriwacki Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity Proc. Natl. Acad. Sci. U. S. A. 93 1996 11504 11509
16. N.P. Pavletich Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors J. Mol. Biol. 287 1999 821 828
17. M. Cheng The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts EMBO J. 18 1999 1571 1583
18. C.S. Haarmann The random-coil 'C' fragment of the dihydropyridine receptor II-III loop can activate or inhibit native skeletal ryanodine receptors Biochem. J. 372 2003 305 316
19. J. Ma Stimulatory and inhibitory functions of the R domain on CFTR chloride channel News Physiol. Sci. 15 2000 154 158
20. N. Olashaw Cell cycle control: a complex issue Cell Cycle 3 2004 263 264
21. E.R. Lacy p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding Nat. Struct. Mol. Biol. 11 2004 358 364
22. H. Zhang p21-containing cyclin kinases exist in both active and inactive states Genes Dev. 8 1994 1750 1758
23. P. Tompa Calpastatin subdomains A and C are activators of calpain J. Biol. Chem. 277 2002 9022 9026
24. S. Barnoy, and N.S. Kosower Caspase-1-induced calpastatin degradation in myoblast differentiation and fusion: cross-talk between the caspase and calpain systems FEBS Lett. 546 2003 213 217
25. P. Tompa The functional benefits of protein disorder J. Mol. Struct. THEOCHEM 666-667 2003 361 371
26. J. Yang Interaction of inhibitor-2 with the catalytic subunit of type 1 protein phosphatase. Identification of a sequence analogous to the consensus type 1 protein phosphatase-binding motif J. Biol. Chem. 275 2000 22635 22644
27. H.Y. Tung Regulation of chromosome segregation by Glc8p, a structural homolog of mammalian inhibitor 2 that functions as both an activator and an inhibitor of yeast protein phosphatase 1 Mol. Cell. Biol. 15 1995 6064 6074
28. P.V. Jallepalli Securin is required for chromosomal stability in human cells Cell 105 2001 445 457
29. N.C. Hornig The dual mechanism of separase regulation by securin Curr. Biol. 12 2002 973 982
30. F. Uhlmann Separase regulation during mitosis Biochem. Soc. Symp. 70 2003 243 251
31. J.P. DiNitto, and P.W. Huber Mutual induced fit binding of Xenopus ribosomal protein L5 to 5S rRNA J. Mol. Biol. 330 2003 979 992
32. M.S. Dai, and H. Lu Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5 J. Biol. Chem. 279 2004 44475 44482
33. V. Ruvolo The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression Proc. Natl. Acad. Sci. U. S. A. 95 1998 8852 8857
34. Z. Zhang MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53 J. Biol. Chem. 279 2004 16000 16006
35. S. Saji MDM2 enhances the function of estrogen receptor α in human breast cancer cells Biochem. Biophys. Res. Commun. 281 2001 259 265
36. M. Domanski Coupling of folding and binding of thymosin β4 upon interaction with monomeric actin monitored by nuclear magnetic resonance J. Biol. Chem. 279 2004 23637 23645
37. I. Bock-Marquette Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair Nature 432 2004 466 472
38. M. Hertzog Control of actin dynamics by proteins made of β-thymosin repeats: the actobindin family J. Biol. Chem. 277 2002 14786 14792
39. M. Hertzog The β-thymosin/WH2 domain; structural basis for the switch from inhibition to promotion of actin assembly Cell 117 2004 611 623
40. J. Liao Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Stat1 interaction Proc. Natl. Acad. Sci. U. S. A. 97 2000 5267 5272
41. T. Megidish Activation of p53 by protein inhibitor of activated Stat1 (PIAS1) J. Biol. Chem. 277 2002 8255 8259
42. B.C. Valdez Cloning and characterization of Gu/RH-II binding protein Biochem. Biophys. Res. Commun. 234 1997 335 340
43. C. Fabrega Structure of an mRNA capping enzyme bound to the phosphorylated carboxy-terminal domain of RNA polymerase II Mol. Cell 11 2003 1549 1561
44. M.A. Breidenbach, and A.T. Brunger Substrate recognition strategy for botulinum neurotoxin serotype A Nature 432 2004 925 929
45. E.M. Schwiebert CFTR is a conductance regulator as well as a chloride channel Physiol. Rev. 79 1999 S145 S166
46. A.C. Gavin Functional organization of the yeast proteome by systematic analysis of protein complexes Nature 415 2002 141 147
47. L.C. James, and D.S. Tawfik Conformational diversity and protein evolution - a 60-year-old hypothesis revisited Trends Biochem. Sci. 28 2003 361 368
48. Z. Dosztányi The pairwise energy content estimated from amino acid composition discriminates between folded and intrinsically unstructured proteins J. Mol. Biol. 347 2005 827 839
49. J.D. Young Thymosin β4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids Nat. Med. 5 1999 1424 1427